Fletcher Allen, a Vermont university hospital and medical center, serves all of
Vermont and the northern New York region. Located in Burlington, Fletcher Allen is a regional, academic healthcare center and teaching hospital in alliance with the University of Vermont.
Our Fellows - Hematology and Oncology Fellowship Program
Fellow: Alka Srivastava, MD
Year: 1998-2001
Internal Medicine Residency: State University of New York Health Science Center of Brooklyn, NY
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: Attending physician, Winter Cancer Center, Ogdensburg, NY
Practice or research interests: Community Clinical Practice of Hematology/Oncology
Fellow: Margaret Kennedy, MD, MSc
Year: 1999 - 2002
Internal Medicine Residency: St. Luke's - Roosevelt Hospital Center, NY
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: Associate Director of Hemostasis Thrombosis Laboratory, Western Pennsylvania Cancer Institute, Director of Therapeutic Apheresis, Western Pennsylvania Hospital, West Penn Allegheny Health System, PA
Practice or research interests: Coagulation and general hematology
Fellow: Zafer Yildirim, MD, PhD
Year: 2000 - 2003
Internal Medicine Residency: Michigan State University College of Human Medicine/Spectrum Health
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: Attending physician, St. John Medical Center, Longview, WA
Practice or research interests: Tumor immunology and critical care
Fellow: Chris Holmes, MD, PhD
Year: 2001- 2004
Internal Medicine Residency: University of Vermont/Fletcher Allen, VT
Chief Medical Resident: University of Vermont/Fletcher Allen, VT
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: Associate Professor of Medicine and Attending Physician, Hematology-Oncology Unit, University of Vermont College of Medicine/Fletcher Allen Health Care, VT
Practice or research interests: Platelet biology; coagulation and cancer; Hematology
Fellow: Aqeel Gillani, MBBS
Year: 2001- 2004
Internal Medicine Residency: Michigan State University, Kalamazoo, MI
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: Attending Physician,C.R Wood Cancer Center, Glens Falls, NY
In 2007, he received a three-year appointment as Cancer Liaison Physician for the cancer program at Glens Falls Hospital
Practice or research interests: Hematology & Medical Oncology; Lung Cancer
Fellow: William Eric Spielvogle, MD
Year: 2001- 2004
Internal Medicine Residency: Mercy Hospital of Pittsburgh
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: Attending physician, UPMC Horizon, and Jameson Hospital, PA
Practice or research interests: Breast Cancer, Cancer Genetics, General Hematology/Oncology
Fellow: Matthew Dugan, DO
Year: 2002- 2005
Internal Medicine Residency: Maine Medical Center, Portland, ME
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: Maine Center for Cancer Medicine, Portland, ME
Practice or research interests: Hematology & Medical Oncology; Supportive care; Anti-emetic clinical trials
Fellow: Jonathan Eneman, MD
Year: 2002- 2005
Internal Medicine Residency: Beth Israel Deaconess Medical Center, Boston, MA
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: York Hospital, York, ME
Practice or research interests: Hematology & Medical Oncology; Community cancer center administration; Cancer and end-stage renal disease
Fellow: Musaberk Goksel, MD
Year: 2003- 2006
Internal Medicine Residency: Mercy Hospital and Medical Center, Chicago, IL
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: Kosciusko Community Hospital Cancer Center, Warsaw, IN
Practice or research interests: Hematology & Medical Oncology
Fellow: Marisa Siebel, MD
Year: 2003- 2006
Internal Medicine Residency: Maimonides Medical Center, Brooklyn, NY
Board Certifications: Internal Medicine; Hematology; Medical Oncology
Current Position: Assistant Professor, State University of New York at Stony Brook, NY
Practice or research interests: Medical Oncology; Gastrointestinal Oncology
Fellow: Julian Sprague, MD, PhD
Year: 2004 - 2007
Internal Medicine Residency: University of Vermont/Fletcher Allen
Board Certifications: Internal Medicine, Hematology; Medical Oncology
Current Position: Assistant Professor of Medicine and Attending Physician, Hematology-Oncology Unit, University of Vermont College of Medicine/Fletcher Allen Health Care, VT
Practice or research interests: Hematologic malignancies, Director, Hematology/Oncology Fellowship Program
Fellow: Sabrina Witherby, MD
Year: 2004- 2007
Internal Medicine Residency: Brown University, RI
Board Certifications: Internal Medicine, Hematology; Medical Oncology
Current Position: Clinician educator at Memorial Hospital of Pawtucket, Brown University, RI
Practice or research interests: Geriatric oncology; Breast cancer; Ethics
Fellow: Kim Dittus, MD, PhD
Year: 2005- 2008
Internal Medicine Residency: East Tennessee State University, TN
Board Certifications: Internal Medicine, Hematology; Medical Oncology
Current Position: Assistant Professor of Medicine and Attending Physician, Hematology-Oncology Unit, University of Vermont College of Medicine/Fletcher Allen Health Care, VT
Practice interests: Hematology; Oncology; Breast Cancer
Research interests: Exercise and cancer; Patient-oriented research
Fellow: Regan Holdridge, MD
Year: 2005- 2008
Internal Medicine Residency: University of Vermont/Fletcher Allen
Board Certifications: Internal Medicine, Hematology; Medical Oncology
Current Position: Attending physician practicing hematology and oncology for Comprehensive Cancer Centers of Nevada, in Las Vegas, NV
Practice or research interests: Breast oncology; Clinical practice
Fellow: Steve Emmons, MD
Year: 2006- 2009
Internal Medicine Residency: Arizona Health Sciences Center, Tucson, AZ
Board Certifications: Internal Medicine, Hematology; Medical Oncology
Current Position: Assistant Professor of Medicine and Attending Physician, Hematology-Oncology Unit, University of Vermont College of Medicine/Fletcher Allen Health Care, VT and Adirondack Medical Center, Saranac Lake, NY
Practice or research interests: Hematology, Medical Oncology
Fellow: Todd Whitman, MD
Year: 2006- 2009
Internal Medicine Residency: University of Vermont/Fletcher Allen, VT
Board Certification: Internal Medicine; Medical Oncology
Current Position: Champlain Valley Physicians Hospital, Plattsburgh, NY
Practice or research interests: Hematology/Medical Oncology
Fellow: Farrah Khan, MD
Year: 2007- 2010
Internal Medicine Residency: St. Elizabeth Medical Center, Boston, MA
Board Certification: Internal Medicine; Medical Oncology
Current Position: Attending Physician, Fletcher Allen, Burlington, VT
Practice or research interests: Oncology, Breast cancer-related research
Fellow: Madhuri Vithala, MD
Year: 2007- 2010
Internal Medicine Residency: University of Connecticut Health Center, Farmington, CT
Board Certification: Internal Medicine; Medical Oncology
Current Position: Attending Physician and Assistant Professor, Duke University, Duke VA Hospital
Practice or research interests: Breast, head and neck cancer, Supportive Oncology and Palliative Care
Fellow: Masanori Mori, MD
Year: 2008 - 2011
Internal Medicine Residency: Beth Israel Medical Center, New York, NY
Board Certification: Internal Medicine; Hematology; Medical Oncology
Current Position: Attending Physician, Palliative Care, Seirei Hamamatsu Hospital, Hamamatsu, Shizouka, Japan
Research interest: Supportive Oncology, Symptom Control and Palliative Care in Cancer Patients, Quality of Life, and End-of-life care
Fellow: Nadia Bambace, MD
Year: 2008 - 2011
Internal Medicine Residency: University of Vermont/Fletcher Allen, VT
Board Certification: Internal Medicine; Hematology; Medical Oncology
Current Position: Fellow, McGill University, Montreal - Stem cell transplantation
Practice interest: Benign and malignant hematology (academic)
Research interest: Platelets and angiogenesis; Clinical research - Malignant hematology
Fellow: Deborah Abrams, MD
Year: 2009 - 2012
Internal Medicine Residency: Maine Medical Center, Portland, ME
Board Certification: Internal Medicine
Current Position: 3rd year fellow
Practice interest: Genetic risk evaluation, GI cancers, breast cancer
Research interest: Supportive care; genetics
Fellow: N. Brad Adams, MD
Year: 2009 - 2012
Internal Medicine Residency: University of Vermont/Fletcher Allen, VT
Board Certification: Internal Medicine
Current Position: 3rd year fellow
Practice interest: Hematology and Oncology
Research interest: Thrombosis
Fellow: M. Mansoor Alam, MD
Year: 2010 - 2013
Internal Medicine Residency: Cleveland Clinic, Cleveland, OH
Board Certification: Internal Medicine
Current Position: 2nd year fellow
Practice interest: Hematology and Oncology
Fellow: Edress Othman, MD
Year: 2010 - 2013
Internal Medicine Residency: SUNY, Buffalo, NY
Board Certification: Internal Medicine
Current Position: 2nd year fellow
Practice interest: Hematology and Oncology
Fellow: Julia Moukharskaya, MD
Year: 2011 - 2014
Internal Medicine Residency: East Tennessee State University, TN
Current Position: 1st year fellow
Practice interest: Hematology and Oncology
Fellow: John Winters, III, MD
Year: 2011 - 2014
Internal Medicine Residency: University of New Mexico
Current Position: 1st year fellow
Practice interest: Hematology and Oncology
Fellows' Scholarly Activities
Research Projects
Quality of Life in Premenopausal Women with Metastatic Breast Cancer Treated with GnRH Agonist and an Aromatase Inhibitor - Maria Siebel, M.D., Susan Burdette-Radoux, M.D.
Margaret Kennedy, MD. Hematology/Oncology Fellowship Research. Genetic Risk Factors for Venous Thrombosis in Cancer Patients. 2000-01. Funding, CALGB Foundation Clinical Research Award.2001-03. NHLBI Hemostasis and Thrombosis Training Grant. Finalist,Jeremiah and Rose Stamler Research Award for New Investigators, American Heart Association Council on Epidemiology and Prevention, 2003.
Neil Zakai, MD. Internal Medicine Residency and Hematology-Oncology Fellowship Research. Anemia and the risk of mortality in the elderly. Efficacy of Deep Venous ThrombosisProphylaxis in Medical Inpatients. 7/2007.
Publications
Grunberg SM, Greenblatt M, Ospina D, Valentine J: Phase I/IIStudy of Paclitaxel/Vinorelbine for Advanced Non-Small Cell LungCancer. Lung Cancer 29 Suppl 1:56, 2000.
Andreescu ACM, Cushman M, Hammond JM, Wood ME: Trousseau’s syndrome treated with long-term subcutaneous lepirudin: case report and review of the literature. J Thromb Thrombolysis 11(1): 33-37, 2001.
Srivastava A, McKinnon W, Wood ME: Risk of breast and ovarian cancer in women with strong family histories. Oncology (Huntingt). 15(7):889-902, 2001.
Grunberg SM, Srivastava A, Grunberg KJ, Weeks J: Intensity of Chemotherapy-Induced Emesis and Overall Survival as Determinants of a Global Utility Score. Support Care Cancer 10:624-629, 2002.
Holmes C, Muss HB: Diagnosis and Treatment of Breast Cancer in the Elderly. CA Cancer J Clin 53:227-244, 2003.
Eneman JD, Wood ME, Muss HB: Selecting Adjuvant Endocrine Therapy for Breast Cancer. Oncology 18(14):1733-1744, 2004.
Eneman JD, Wood ME, Muss HB: Selecting Adjuvant Endocrine Therapy for Breast Cancer. Oncology (Huntingt), 18(14):1733-44, 2004.
Zakai N, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost 2004;2:2156-61.
Siebel MF, Muss, HB: The Influence of Aging on the Early Detection, Diagnosis, and Treatment of Breast Cancer. Current OncologyReports 7(1):23-30, 2005.
Kennedy M, Andreescu ACM, Greenblatt MS, Jiang H, Thomas CA,Chassereau L, Wong C, Durda P, Cushman M. Factor V Leiden,prothrombin 20210A and the risk of venous thrombosis among cancerpatients. British J Haematol 2005;128:386-8.
Kennedy M, Solomon C, Manolio TA, Criqui MH, Newman AB, Polak JF, Burke GL,Enright P, Cushman M. Risk factors for worsening ankle-brachial indexin men and women 65 years or older: the Cardiovascular Health Study.Arch Intern Med 2005;165:1896-1902.
Grunberg SM, Dugan MC, Greenblatt MS, Ospina DJ, Valentine JW:Phase I/II trial of Paclitaxel and Vinorelbine in advanced non-small cell lung cancer, Cancer Investigation 23:392-398 2005.
Witherby SM, Muss HB: Special Issues Related to Breast Cancer Adjuvant Therapy in Older Women. The Breast 14:600-611, 2005.
Witherby SM, Muss HB: Update in Medical Oncology for OlderPatients: Focus on Breast Cancer: Management of Early Breast Cancer.Cancer J 11:506-17, 2005.
Eneman J, Philips G: Cancer Management and Chemotherapy Use in Patients with End-Stage Renal Disease. Oncology 19:1199-1212, 2005.
Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves P, Newman A,Cushman M. Prospective study of anemia status, hemoglobin and mortalityin the elderly: the Cardiovascular Health Study. Arch Intern Med2005;165:1-7.
Witherby SM: Muss HB: Managing Early Stage Breast Cancer in Your Older Patients. Oncology 20(9)1003-1012, 2006.
Sprague JR, Wood ME: Statins and breast cancer prevention:time for randomized controlled trials. J Clin Oncol. 24(13):2129-30,author reply 2130-1, 2006.
Sprague J, Wood M: Breast cancer prevention: time for randomized controlled trials with statins. Arch Intern Med 166(10):1143-4, 2006.
Grunberg S, Dugan M, Chassereau L, Fingar J, Rivers K,Burdette-Radoux S: Prevention of Moderately Emetogenic Chemotherapy-Induced Nausea and Vomiting with a 1-Day 3-Drug Antiemetic Regimen – Preliminary Report. Support Care Cancer 14:596, 2006
Dittus K, Muss HB: “Management of the Frail Elderly with Breast Cancer”. Oncology 21(14): 1727-1734, 2007.
Witherby SM, Butnor KJ, Grunberg SM: Malignant MesotheliomaFollowing Thoracic Radiotherapy for Lung Cancer. Lung Cancer57:410-413, 2007.
Grunberg SM, Dugan M, Muss HB, Wood M, Burdette-Radoux SB, Weisberg T: Efficacy of a 1-Day 3-Drug Antiemetic Regimen for Prevention of Acute and Delayed Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy. J Clin Oncol 25:520s, 2007 (Suppl:Abstract 9111).
Zakai N, Jenny NS, Tracy RP, Reiner AP,Psaty BM, Schwartz S, Cushman M. Comparison of multiple inflammatory markers in the prediction of cardiovascular disease in older men and women. J Thromb Haemost 2007;5:1128-35.
Casey TM, Eneman J,Crocker A, Tessitore J, Stanley M, Harlow S, Bunn JY, Weaver D, Muss H,Plaut K. Cancer Associated Fibroblasts Stimulated by Transforming Growth Factor Beta1 (TGF-?1) Increase Invasion Rate of Tumor Cells: APopulation Study. Breast Cancer Res Treat, 110(1):39-49, 2008.
Zakai NA, Ohira T, White R, Folsom AR, Cushman M. Prospective study of theactivated partial thromboplastin time and risk of incident venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. In Press (2008) Am J Med.
Suzuki T, Katz R, Jenny NS, LeWinter MM, Zakai NA, BarzilayJI, Cushman M. Metabolic syndrome, inflammation, and the incidence of congestive heart failure in the elderly: the Cardiovascular HealthStudy. Submitted.
Gillani AA, Grunberg SM..Aerorespiratory tract cancer in older patients. Semin Oncol. 2004 Apr:31 (2):220-33.
Bambace NM, Levis JE, Holmes Ce. The Effect of P2Y-Mediated Activation on VEGF and Endostatin Release from Platelets. Platelets. 2010; 21(2): 85-93.
Rabinowitz-Abrams, D, Morgan D, Morse J, Miesfeldt S. Building a tool to identify risk for Lynch Syndrome among individuals presenting for screening colonoscopy. J Genet Counsel. 2010 Mar 27. [Epub ahead of print]
Mori M, Bruera E, Dev R. Complications of a gastrostomy tube used for decompression of an inoperable bowel obstruction in a patient with advanced cancer. J Pain Symptom Manage. 2009 Sep;38(3):466-72. Epub 2009 Apr 9.
Hui D, Mori M, Parsons HA, Kim SH, Li Z, Damani S, Bruera E. The lack of standard definitions in the supportive and palliative oncology literature. Manuscript accepted by J Pain Symptom Manage in April 2011.
Mori M, Parsons AH, De La Cruz M, Elsayem A, Palla SL, Liu J, Li Z, Palmer L, Bruera E, Fadul N. Changes in symptoms and inpatient mortality: a study in advanced cancer patients admitted to an acute palliative care unit in a comprehensive cancer center. Manuscript accepted by the J Palliat Med.
Mori M, Elsayem A, Reddy SK, Bruera E, Fadul NA. Unrelieved pain and suffering in patients with advanced cancer. Manuscript accepted by the Am J Hosp Palliat Med.
Bambace NM, Holmes CE. The Platelet Contribution to Cancer Progression. J Thromb Haemost. 2010; 9: 237-249.
Book Chapters
Srivastava A, Wood ME: Polycytnemic States. In: Hematology/Oncology Secrets, 3rd edition, Hanley & Belfus 2003.
Muss HB, Holmes CE: "Tailored System Therapy for the ElderlyWoman". Breast Cancer Management and Molecular Medicine: TowardsTailored Approaches. (ed) Piccart M; Wood WC, -C Hung M, Solin LE,Cardoso F. Springer-Verlay Berlin – publishers (19:375-396, 2006).
Grunberg SM, Bibawi S: Lung Cancer. In: Hunter CP, Johnson KA, Muss HB (eds). Cancer in the Elderly, New York, Marcel Dekker, 2000, pp 345-360.
Spielvogle WE, Grunberg S: Primary Brain Tumors. In: Wood ME, Philips GK (eds). Hematology/Oncology Secrets - 3rd Edition,Philadelphia, Hanley & Belfus, 2003, pp 358-361.
Grunberg SM, Dugan M: Integrated Therapy of Nausea andVomiting. In: Hesketh P (ed.) Management of Nausea and Vomiting in Cancer and Cancer Treatment, Sudbury, MA, Jones and Bartlett Publishers, 2005, pp 147-160.
Grunberg SM, Dugan M, Gralla RJ: Management of Nausea and Vomiting. In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD (eds). Cancer Management: A Multidisciplinary Approach – 9th Edition, New York, CMP Healthcare Media, 2005, pp 875-886.
Witherby S, Grunberg SM: Lung Cancer. In: Muss HB, HunterCP, Johnson KA (eds).Treatment and Management of Cancer in the Elderly,New York, Taylor & Francis, 2006, pp 225-248.
Grunberg SM, Siebel M: Management of Nausea and Vomiting.In: Pazdur R, Coia LR, Hoskins WJ, Wagman LD (eds). Cancer Management: A Multidisciplinary Approach – 10th Edition, Darien, CT,CMP Healthcare Media, 2007, pp 873-884.
Grunberg SM, Mori M, Richard Gralla. Cancer Management: A Multidisciplinary Approach. 12th Edition. Chapter 35. Management of nausea and vomiting. Pp. 893-904. CMPMedia, 2009, ISBN 9781891483639.
Abstracts
Ospina DJ, Unger P, Grunberg SM: Value of Extended Staging in Clinical Stage I Non-Small Cell Lung Cancer. Proc ASCO 17:426A, 1998.
Bibawi S, Chassereau L, Wood M, Muss H, Cooper M: A Phase IStudy of Docetaxel and Mitoxantrone Combination Chemotherapy in Patients with Advanced Solid Tumors. Proc ASCO 18:783, 1999.
Srivastava A, Grunberg KJ, Weeks JC, Grunberg SM: Effect ofEmesis Intensity and Expected Survival on Utility Scores for Chemotherapy-Induced Nausea and Vomiting. Proc ASCO 18:421A, 1999.
Grunberg SM, Greenblatt M, Ospina D, Valentine J: Phase I Study of Paclitaxel/Vinorelbine for Advanced Non-Small Cell Lung Cancer. Proc ASCO 18:507A, 1999.
Sprague JR, McKinnon WC, Wood ME: Comparison of Questionnaire and counseling family history information. Am J Hum Genet 74(4, suppl)Abstr # 1406, 2004.
Witherby SM, Johnson JV, O’Brien P, Demers LM, Mount SL, MussHB: Efficacy and Safety of Vaginal Testosterone for Atrophic Vaginitisin Breast Cancer Patients on Aromatase Inhibitors: A Pilot Study.Breast Cancer Research & Treatment 106(Suppl 1), Abstr #6068, S276,2007.
Grunberg, SM, Dugan M, Muss HB, Wood M, Burdette-Radoux S,Weisberg T. Efficacy of a 1-day 3-drug antiemetic regimen for prevention of acute and delayed nausea and vomiting induced by moderately emetogenic chemotherapy. Journal of Clinical Oncology, 2007ASCO Annual Meeting Proceedings Part I. 25 (Suppl 18S), Abstr # 9111,2007.
Khan FB, Ambaye A, Weaver D, Wood ME, Unger PS, Burdette-Radoux S. "Pathologic Complete Response Rates to Neoadjuvant Chemotherapy from the Vermont Cancer Center Breast Cancer Database: A Retrospective Analysis." Miami Breast Cancer Symposium March 2010.
Khan FB, Kingsley F, Dittus K, Sussman B, Wood ME. Breast Density and Calculated Breast Cancer Risk. J Clin Oncol 28:7s, 2010 (suppl; abstr 1556)
M. Mori, H. A. Parsons, M. De la Cruz, A. F. Elsayem, S. L. Palla, J. Liu, Z. Li, J. L. Palmer, E. Bruera, N. A. Fadul. Changes in symptoms and inpatient mortality among advanced cancer patients admitted to a palliative care unit in a comprehensive cancer center. J Clin Oncol 28:7s, 2010 (suppl; abstr 9065)
Bambace NM, Levis JE, Holmes CE . “The Effect of P2Y-Mediated Activation of VEGF and Endostatin Release from Platelets”, XXII International Society of Thrombosis and Hemostasis Congress 2009 in Boston, MA. July 13, 2009.
Presentations
Kahn, F., Poster presentation, “Pathologic Complete Response Rates to Neoadjuvant Chemotherapy from the Vermont Cancer Center Breast Cancer Database: A Retrospective Analysis”. Miami Breast Cancer Symposium. March 2010.
Khan, F., Poster presented, “Breast density and calculated breast cancer risk.” Annual Meeting of the American Society of Clinical Oncology (ASCO) Chicago, June 4-8, 2010,
Mori M, Homel P, Strada A, Billings A, Tennstedt S, Portenoy R. “Longitudinal changes in symptom distress and quality of life in patients with end-stage chronic disease.” Oral presentation at The Annual Assembly of American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association in Boston, MA, March 5, 2010.
Mori M, Ramsay A. “Fatal liver failure due to gemcitabine in a patient with metastatic breast cancer receiving palliative care.” Oral presentation at The Annual Assembly of American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association in Boston, MA, March 5, 2010.
Mori M, Brus C, Bhatia A, Nishihori T, Blum R. “A multidisciplinary approach for bone metastases.” Oral presentation at The Annual Assembly of American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association in Boston, MA, March 5, 2010.
Mori, M, Poster presentation entitled “Changes in symptoms and inpatient mortality among advanced cancer patients admitted to a palliative care unit in a comprehensive cancer center.” The Annual Meeting of the Multinational Association of Supportive Care in Cancer (MASCC) Vancouver, Canada, June 24-26, 2010 and at Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, June 2010
Madhuri Vithala, MD, Poster presentation entitled “Cetuximab for locally recurrent squamous cell carcinoma of the skin.” The Annual Meeting of the Multinational Association of Supportive Care in Cancer (MASCC) Vancouver June 24-26, 2010.
Mori M, Sprague J. The long-term effect of sorafenib in a FLT3-ITD-positive patient with refractory acute erythroid leukemia. (Poster presentation at Northern New England Clinical Oncology Society Annual Meeting on 10/29/10)
Mori M, Ellison D, McVeigh U, Ramsay A, Ashikaga T, Ades S. Advanced care planning and the quality of inpatient end-of-life care of cancer patients: challenges in an after-death survey study among bereaved primary caregivers. (Poster presentation at the Vermont Cancer Center 2010 Clinical and Translational Research Symposium on 11/5/10.)
Metzelder S, Finck A, Fey M, Scholl S, Kröger M, Reiter A, Salih HR, Götze K, Meyer, RG, Giagounidis A, Brugger W, Vöhringer M, Müller L, Ching LY, Dreger P, Mori M, Basara N, Schaefer-Eckart K, Schultheis B, Baldus C, Neubauer A, Burchert A. Sorafenib monotherapy is effective in relapsed and refractoryFlt3-ITD positive acute myeloid leukemia, particularly after allogenic stem cell transplantation. (Poster presentation at the 52nd American Society of Hematology Annual Meeting and Exposition on 12/6/10, #3314.)
Mori M, Ellison D, McVeigh U, Ramsay A, Ashikaga T, Ades S. Quality improvement in the inpatient end-of-life cancer care: Preliminary results of the after-death survey study among bereaved primary caregivers. (Poster presentation at the 6th Annual Quality Forum at Fletcher Allen Health Care / University of Vermont College of Medicine on 1/12/11.)
Mori M, Ashikaga T, Grunberg SM. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation in cancer patients. Poster to be presented in the Trials in Progress Poster Session at 2011 ASCO Annual Meeting on 6/6/11.
Mori M, Kuwama Y, Parsons HA, Ashikaga T, Grunberg SM, Miyashita M. Acculturation and beliefs about end-of-life (EOL) cancer care among individuals of Japanese ancestry living in America. To be orally presented at the MASCC/ISOO 2011 International Symposium on 6/24/11.
Mori M, Ellison D, Ashikaga T, McVeigh U, Ramsay A, Ades S. Code status (CS) on admission and the quality of inpatient end-of-life (EOL) cancer care: perspectives of bereaved primary caregivers (PCGs). To be orally presented at the MASCC/ISOO 2011 International Symposium on 6/24/11.
Mori M, Kuwama Y, Parsons HA, Ashikaga T, Grunberg SM, Miyashita M. Acculturation and perceptions of good cancer death among individuals of Japanese ancestry living in America. To be orally presented at the MASCC/ISOO 2011 International Symposium in Athens, Greece, on 6/25/11. 2011 MASCC Young Investigator Award based on this abstract.
Mori M, Ellison D, Ashikaga T, McVeigh U, Ramsay A, Ades S. In-advance end-of-life (EOL) discussions and the quality of inpatient EOL cancer care: perspectives of bereaved primary caregivers (PCG). To be orally presented at the MASCC/ISOO 2011 International Symposium in Athens, Greece, on 6/25/11.